US approval for Lyumjev

The FDA has approved Lilly’s Lyumjev rapid-acting mealtime insulin to reduce high blood sugar after meals and keep blood glucose levels in-range. This approval offers

Read More »

ADA endorses US diabetes bills

The American Diabetes Association (ADA) announced the formal endorsement of three bills aiming to reduce the high cost of insulin and prescription drugs.  The Insulin Price

Read More »

Faster insulin, soon

Faster insulin The Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA), has recommended marketing authorisation for Novo Nordisk Fiasp

Read More »